0001700501-17-000002.txt : 20170313 0001700501-17-000002.hdr.sgml : 20170313 20170313154348 ACCESSION NUMBER: 0001700501-17-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170313 DATE AS OF CHANGE: 20170313 EFFECTIVENESS DATE: 20170313 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CERo Therapeutics, Inc. CENTRAL INDEX KEY: 0001700501 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-282417 FILM NUMBER: 17685104 BUSINESS ADDRESS: STREET 1: 329 OYSTER POINT BLVD. STREET 2: 3RD FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 206-658-3462 MAIL ADDRESS: STREET 1: 329 OYSTER POINT BLVD. STREET 2: 3RD FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94080 D 1 primary_doc.xml X0707 D LIVE 0001700501 CERo Therapeutics, Inc. 329 Oyster Point Blvd. 3rd Floor San Francisco CA CALIFORNIA 94080 206-658-3462 DELAWARE None None Corporation true 2016 Lawrence Corey 329 Oyster Point Blvd. 3rd Floor San Francisco CA CALIFORNIA 94080 Executive Officer Director Jordan Thomas Corey 329 Oyster Point Blvd. 3rd Floor San Francisco CA CALIFORNIA 94080 Executive Officer Daniel Mark Corey 329 Oyster Point Blvd. 3rd Floor San Francisco CA CALIFORNIA 94080 Director Other Decline to Disclose 06b false 2017-02-27 false true false 0 2500000 1399999 1100001 false 7 0 0 0 false CERo Therapeutics, Inc. /s/ Jordan Thomas Corey Jordan Thomas Corey Chief Financial Officer 2017-03-12